Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.


Roche (QX) (RHHBY)

Roche Holdings Ltd AG (QX)
Ordernar por:
 Showing the most relevant articles for your search:USOTC:RHHBY
16/01/202400:49Dow Jones NewsRoche's Cancer Injection Tecentriq SC Gets European Commission ApprovalUSOTC:RHHBYRoche Holdings Ltd AG (QX)
10/01/202407:45InvestorsHub NewsWireGLP-1: Beyond Diabetes, a Blockbuster Horizon BeckonsUSOTC:RHHBYRoche Holdings Ltd AG (QX)
29/12/202316:07Dow Jones NewsLumiraDx Agrees to Sell Point-of-Care Tech Platform to RocheUSOTC:RHHBYRoche Holdings Ltd AG (QX)
19/12/202309:27Dow Jones NewsRoche's Xolair Granted FDA Priority ReviewUSOTC:RHHBYRoche Holdings Ltd AG (QX)
11/12/202309:31Dow Jones NewsPoseida Therapeutics Shares Climb on Positive Data for Blood Cancer TreatmentUSOTC:RHHBYRoche Holdings Ltd AG (QX)
08/12/202311:56Dow Jones NewsRoche Obtains Positive Data on Early-Stage Breast Cancer TreatmentUSOTC:RHHBYRoche Holdings Ltd AG (QX)
08/12/202311:38Dow Jones NewsRoche's Inavolisib Breast Cancer Drug Gets Positive ResultsUSOTC:RHHBYRoche Holdings Ltd AG (QX)
06/12/202304:14Dow Jones NewsMerck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage TrialsUSOTC:RHHBYRoche Holdings Ltd AG (QX)
05/12/202300:54Dow Jones NewsRoche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage StudyUSOTC:RHHBYRoche Holdings Ltd AG (QX)
04/12/202309:12Dow Jones NewsTrending: Roche to Buy Carmot Therapeutics in Deal Worth Up to $3.1 BillionUSOTC:RHHBYRoche Holdings Ltd AG (QX)
04/12/202305:34Dow Jones NewsRoche to Buy Carmot Therapeutics for Up to $3.1 Billion in Bet on Obesity Treatments -- UpdateUSOTC:RHHBYRoche Holdings Ltd AG (QX)
04/12/202304:55IH Market NewsAlaska Air Acquires Hawaiian Holdings, Spotify Cuts 1,500 Jobs, Uber’s S&P 500 Entry, and MoreUSOTC:RHHBYRoche Holdings Ltd AG (QX)
04/12/202300:47Dow Jones NewsRoche Strikes Deal to Buy Drug Developer Carmot Therapeutics for $2.7 BillionUSOTC:RHHBYRoche Holdings Ltd AG (QX)
21/11/202310:06Dow Jones NewsRoche's Genentech, Nvidia Team Up to Accelerate Drug Discovery With AIUSOTC:RHHBYRoche Holdings Ltd AG (QX)
07/11/202316:14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:RHHBYRoche Holdings Ltd AG (QX)
31/10/202301:26Dow Jones NewsRoche Says Late-Stage Muscular Dystrophy Trial Didn't Meet Main GoalUSOTC:RHHBYRoche Holdings Ltd AG (QX)
27/10/202300:40Dow Jones NewsRoche Gets FDA Approval for Vabysmo as Retinal Vein Occlusion TreatmentUSOTC:RHHBYRoche Holdings Ltd AG (QX)
23/10/202314:41Dow Jones NewsTrending: Roche to Buy Telavant From Roivant and PfizerUSOTC:RHHBYRoche Holdings Ltd AG (QX)
23/10/202303:16Dow Jones NewsRoche to Buy Telavant From Roivant, Pfizer in Deal Worth Up to $7.25 Billion -- UpdateUSOTC:RHHBYRoche Holdings Ltd AG (QX)
23/10/202300:50Dow Jones NewsRoche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Billion DealUSOTC:RHHBYRoche Holdings Ltd AG (QX)
19/10/202304:55Dow Jones NewsRoche Shares Fall on Lower Sales Due to Currency HitUSOTC:RHHBYRoche Holdings Ltd AG (QX)
19/10/202300:48Dow Jones NewsRoche Backs Guidance After Sales FallUSOTC:RHHBYRoche Holdings Ltd AG (QX)
18/10/202301:14Dow Jones NewsRoche Lung Cancer Drug Reduced Risk of Recurrence, Death in Late-Stage TrialUSOTC:RHHBYRoche Holdings Ltd AG (QX)
18/10/202300:54Dow Jones NewsRoche's Elecsys IL-6 Test Approved for Diagnosis of Neonatal SepsisUSOTC:RHHBYRoche Holdings Ltd AG (QX)
29/09/202307:15Dow Jones NewsAbbVie: Phase 3 Venetoclax/Dexamethasone Study Falls Short in Multiple MyelomaUSOTC:RHHBYRoche Holdings Ltd AG (QX)
27/09/202306:59Dow Jones NewsIonis, Roche Set New Pact Targeting Alzheimer's, Huntington'sUSOTC:RHHBYRoche Holdings Ltd AG (QX)
20/09/202307:45InvestorsHub NewsWirePathways to Progress: How Orphan Drug Designation Sparks Biotech TransformationUSOTC:RHHBYRoche Holdings Ltd AG (QX)
06/09/202300:52Dow Jones NewsRoche's Blood Disorder Drug Crovalimab Takes Step Toward FDA ApprovalUSOTC:RHHBYRoche Holdings Ltd AG (QX)
01/09/202301:04Dow Jones NewsRoche Lung Cancer Drug Shows Promise in Phase 3 TrialUSOTC:RHHBYRoche Holdings Ltd AG (QX)
29/08/202304:51Dow Jones NewsRoche's Tecentriq Intravenous Cancer Therapy Gets UK ApprovalUSOTC:RHHBYRoche Holdings Ltd AG (QX)
 Showing the most relevant articles for your search:USOTC:RHHBY